A citation-based method for searching scientific literature

Nathalie Grandin, Bruno Pereira, Camille Cohen, Pauline Billard, Caroline Dehais, Catherine Carpentier, Ahmed Idbaih, Franck Bielle, François Ducray, Dominique Figarella-Branger, Jean-Yves Delattre, Marc Sanson, Patrick Lomonte, Delphine Poncet, Pierre Verrelle, Michel Charbonneau. Acta Neuropathol Commun 2019
Times Cited: 2







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Strand break-induced replication fork collapse leads to C-circles, C-overhangs and telomeric recombination.
Tianpeng Zhang, Zepeng Zhang, Gong Shengzhao, Xiaocui Li, Haiying Liu, Yong Zhao. PLoS Genet 2019
19
100

The C-Circle Assay for alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Loretta M Lau, Sylvia Koch, Nancy Martin La Rotta, Rebecca A Dagg, Roger R Reddel. Methods 2017
48
100

A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Jeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, Janice A Royds, Thomas R Yeager, Robert A Robinson, Stephen B Wharton, David A Jellinek, Susan M Arbuckle, Jinyoung Yoo,[...]. Clin Cancer Res 2005
201
100

DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Ying Cao, Lily I Huschtscha, Andy C Chang, Amy Y M Au, Hilda A Pickett, Roger R Reddel. Nat Biotechnol 2009
260
100

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
155
50

The RNA component of human telomerase.
J Feng, W D Funk, S S Wang, S L Weinrich, A A Avilion, C P Chiu, R R Adams, E Chang, R C Allsopp, J Yu. Science 1995
50


ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status.
Audrey Laroche-Clary, Vanessa Chaire, Stéphanie Verbeke, Marie-Paule Algéo, Andrei Malykh, François Le Loarer, Antoine Italiano. Sci Rep 2020
2
50

Telomere sequence content can be used to determine ALT activity in tumours.
Michael Lee, Erdahl T Teber, Oliver Holmes, Katia Nones, Ann-Marie Patch, Rebecca A Dagg, Loretta M S Lau, Joyce H Lee, Christine E Napier, Jonathan W Arthur,[...]. Nucleic Acids Res 2018
14
50

Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
Joshua Mangerel, Aryeh Price, Pedro Castelo-Branco, Jack Brzezinski, Pawel Buczkowicz, Patricia Rakopoulos, Diana Merino, Berivan Baskin, Jonathan Wasserman, Matthew Mistry,[...]. Acta Neuropathol 2014
27
50

Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Gary A Ulaner, Andrew R Hoffman, Jesse Otero, Hsuan-Ying Huang, Zhiquan Zhao, Madhu Mazumdar, Richard Gorlick, Paul Meyers, John H Healey, Marc Ladanyi. Genes Chromosomes Cancer 2004
69
50

Alternative Lengthening of Telomeres: DNA Repair Pathways Converge.
Alexander P Sobinoff, Hilda A Pickett. Trends Genet 2017
64
50

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations.
Xiao-Yang Liu, Noha Gerges, Andrey Korshunov, Nesrin Sabha, Dong-Anh Khuong-Quang, Adam M Fontebasso, Adam Fleming, Djihad Hadjadj, Jeremy Schwartzentruber, Jacek Majewski,[...]. Acta Neuropathol 2012
238
50

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
50

The essential kinase ATR: ensuring faithful duplication of a challenging genome.
Joshua C Saldivar, David Cortez, Karlene A Cimprich. Nat Rev Mol Cell Biol 2017
252
50

G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.
Roberta Amato, Martina Valenzuela, Francesco Berardinelli, Erica Salvati, Carmen Maresca, Stefano Leone, Antonio Antoccia, Antonella Sgura. Genes (Basel) 2020
9
50

FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.
Xiaolei Pan, William C Drosopoulos, Louisa Sethi, Advaitha Madireddy, Carl L Schildkraut, Dong Zhang. Proc Natl Acad Sci U S A 2017
47
50

Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
Kathleen Dorris, Matthew Sobo, Arzu Onar-Thomas, Eshini Panditharatna, Charles B Stevenson, Sharon L Gardner, Mariko D Dewire, Christopher R Pierson, Randal Olshefski, Sandra A Rempel,[...]. J Neurooncol 2014
27
50

Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Daniel Winchester, Julia Lehman, Tiffany Tello, Nicolette Chimato, Thomas Hocker, Sunhee Kim, Joseph Chang, Jeffrey Markey, Sue S Yom, William Ryan,[...]. J Am Acad Dermatol 2018
12
50

The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.
Malak Abedalthagafi, Joanna J Phillips, Grace E Kim, Sabine Mueller, Daphne A Haas-Kogen, Roxanne E Marshall, Sidney E Croul, Mariarita R Santi, Jing Cheng, Shengmei Zhou,[...]. Mod Pathol 2013
70
50

Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.
Doreen N Palsgrove, Jacqueline A Brosnan-Cashman, Caterina Giannini, Aditya Raghunathan, Mark Jentoft, Chetan Bettegowda, Murat Gokden, Doris Lin, Ming Yuan, Ming-Tseh Lin,[...]. Mod Pathol 2018
14
50


Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors.
Christopher J VandenBussche, Derek B Allison, Mindy K Graham, Vivek Charu, Anne Marie Lennon, Christopher L Wolfgang, Ralph H Hruban, Christopher M Heaphy. Cancer Cytopathol 2017
22
50

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup.
Chang S Chan, Saurabh V Laddha, Peter W Lewis, Matthew S Koletsky, Kenneth Robzyk, Edaise Da Silva, Paula J Torres, Brian R Untch, Janet Li, Promita Bose,[...]. Nat Commun 2018
50
50

Leiomyosarcoma.
César Serrano, Suzanne George. Hematol Oncol Clin North Am 2013
51
50

Telomerase-specific replication-selective virotherapy for human cancer.
Takeshi Kawashima, Shunsuke Kagawa, Naoya Kobayashi, Yoshiko Shirakiya, Tatsuo Umeoka, Fuminori Teraishi, Masaki Taki, Satoru Kyo, Noriaki Tanaka, Toshiyoshi Fujiwara. Clin Cancer Res 2004
159
50


CSB cooperates with SMARCAL1 to maintain telomere stability in ALT cells.
Emily Feng, Nicole L Batenburg, John R Walker, Angus Ho, Taylor R H Mitchell, Jian Qin, Xu-Dong Zhu. J Cell Sci 2020
2
50

Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas.
Fausto J Rodriguez, M Adelita Vizcaino, Jaishri Blakeley, Christopher M Heaphy. Acta Neuropathol 2016
15
50

Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands.
Gaëlle Pennarun, Christine Granotier, Laurent R Gauthier, Dennis Gomez, Françoise Hoffschir, Eliane Mandine, Jean-François Riou, Jean-Louis Mergny, Patrick Mailliet, François D Boussin. Oncogene 2005
177
50

Angiosarcoma.
Robin J Young, Nicola J Brown, Malcolm W Reed, David Hughes, Penella J Woll. Lancet Oncol 2010
397
50

Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
Eloïse Claude, Anabelle Decottignies. Curr Opin Genet Dev 2020
6
50

RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells.
Rajika Arora, Yongwoo Lee, Harry Wischnewski, Catherine M Brun, Tobias Schwarz, Claus M Azzalin. Nat Commun 2014
189
50

Genistein suppresses the proliferation of telomerase-negative cells.
Chuan-Chuan Lin, Meng-Hsun Hsieh, Shu-Chun Teng. Food Sci Nutr 2016
3
50

FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops.
Xiaolei Pan, Yun Chen, Beena Biju, Naveed Ahmed, Joyce Kong, Marti Goldenberg, Judy Huang, Nandakumar Mohan, Stephanie Klosek, Kian Parsa,[...]. Sci Rep 2019
10
50

Uterine smooth muscle tumors of unknown malignant potential: A challenging question.
Angiolo Gadducci, Gian Franco Zannoni. Gynecol Oncol 2019
16
50

Liposarcoma: Multimodality Management and Future Targeted Therapies.
Aimee M Crago, Mark A Dickson. Surg Oncol Clin N Am 2016
42
50

Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular Entity.
Gerrit H Gielen, Marco Gessi, Francesca R Buttarelli, Caterina Baldi, Jennifer Hammes, Anja zur Muehlen, Evelyn Doerner, Dorota Denkhaus, Monika Warmuth-Metz, Felice Giangaspero,[...]. Brain Pathol 2015
21
50

Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.
Andrea Dall'Asta, Salvatore Gizzo, Andrea Musarò, Michela Quaranta, Marco Noventa, Costanza Migliavacca, Giulio Sozzi, Michela Monica, Daniele Mautone, Roberto Berretta. Int J Clin Exp Pathol 2014
30
50

Telomerase catalytic subunit homologs from fission yeast and human.
T M Nakamura, G B Morin, K B Chapman, S L Weinrich, W H Andrews, J Lingner, C B Harley, T R Cech. Science 1997
50

Inhibition of MUC1 exerts cell-cycle arrest and telomerase suppression in glioblastoma cells.
Sojin Kim, Youngbeom Seo, Tamrin Chowdhury, Hyeon Jong Yu, Chae Eun Lee, Kyung-Min Kim, Ho Kang, Hak Jae Kim, Soo-Ji Park, Kyoungmi Kim,[...]. Sci Rep 2020
2
50

Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma.
Joydeep Mukherjee, Tor-Christian Johannessen, Shigeo Ohba, Tracy T Chow, Lindsey Jones, Ajay Pandita, Russell O Pieper. Cancer Res 2018
29
50

Telomere damage induces internal loops that generate telomeric circles.
Giulia Mazzucco, Armela Huda, Martina Galli, Daniele Piccini, Michele Giannattasio, Fabio Pessina, Ylli Doksani. Nat Commun 2020
3
50

The molecular pathogenesis of osteosarcoma: a review.
Matthew L Broadhead, Jonathan C M Clark, Damian E Myers, Crispin R Dass, Peter F M Choong. Sarcoma 2011
208
50


SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.
Nathaniel J Robinson, Chevaun D Morrison-Smith, Alex J Gooding, Barbara J Schiemann, Mark W Jackson, Derek J Taylor, William P Schiemann. Life Sci Alliance 2020
3
50

Genetics of pancreatic neuroendocrine tumors: implications for the clinic.
Antonio Pea, Ralph H Hruban, Laura D Wood. Expert Rev Gastroenterol Hepatol 2015
19
50


Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers.
Meng-Hsun Hsieh, Cheng-Hui Tsai, Chuan-Chuan Lin, Tsai-Kun Li, Ting-Wei Hung, Li-Te Chang, Ling-Wei Hsin, Shu-Chun Teng. Cell Mol Life Sci 2015
5
50

Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres.
Rebecca A Dagg, Hilda A Pickett, Axel A Neumann, Christine E Napier, Jeremy D Henson, Erdahl T Teber, Jonathan W Arthur, C Patrick Reynolds, Jayne Murray, Michelle Haber,[...]. Cell Rep 2017
33
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.